AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
B
HighReliability
B - HighIncorporation date
26/09/2011Share capital
5,000.00 PLNPrimary activity
Agents specialised in the sale of particular products or ranges of other products (46.18.Z - PKD 2007)Representatives
0Representatives rights
SPÓŁKĘ REPREZENTUJE DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE LUB CZŁONEK ZARZĄDU DZIAŁAJĄCY ŁĄCZNIE Z PROKURENTEM.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
3,067,233Net Profit (zł)
3,067,233Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 50,986,758 |
| 3,527,486 |
| 2,634,980 |
| 0.27 |
| 5.58 |
| 5.17 |
| 9,784,056 |
| 3,013,398 |
| 0 |
| 956,215 |
| 2023 |
|---|
| 50,406,162 |
| 3,733,048 |
| 2,889,811 |
| 0.34 |
| 9.36 |
| 5.73 |
| 12,673,867 |
| 2,073,867 |
| - |
| 440,684 |
| 2024 |
|---|
| 50,515,472 |
| 4,092,622 |
| 3,067,233 |
| 0.38 |
| 3.96 |
| 6.07 |
| 15,741,100 |
| 6,415,155 |
| - |
| 415,067 |
| 2024 |
|---|
| 50,515,472 |
| 4,092,622 |
| 3,067,233 |
| 0.38 |
| 3.96 |
| 6.07 |
| 15,741,100 |
| 6,415,155 |
| - |
| 415,067 |
Turnover (zł)
2024
Turnover (zł)
50,515,472 zł
0 % *
Profit before tax (zł)
4,092,622 zł10 % *
Net Profit (zł)
3,067,233 zł6 % *
Working capital requirement (%)
0.38 
11.76 % *
Liquidity ratio
3.96 
-57.69 % *
Net profitability (%)
6.07 %5.93 % *
Equity (zł)
15,741,100 zł24 % *
Current liabilities (zł)
6,415,155 zł209 % *
Non current liabilities (zł)
-Non-current Assets (zł)
415,067 zł
-6 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
11/07/2025 | OD 01.01.2024 DO 31.12.2024 |
21/06/2024 | OD 01.01.2023 DO 31.12.2023 |
06/06/2023 | OD 01.01.2022 DO 31.12.2022 |
26/08/2022 | OD 01.01.2021 DO 31.12.2021 |
28/06/2021 | OD 01.01.2020 DO 31.12.2020 |